Valuation: Bonus BioGroup Ltd.

Market Cap 206M 0 65.46M 58.44M 53.63M 48.79M 91.47M 6.2B 93.29M 641M 258M 3.27B 246M 240M 10.33B P/E 2024
-4.99x
P/E 2025 -12x
Enterprise Value 214M 0 68.22M 60.91M 55.89M 50.84M 95.32M 6.46B 97.22M 668M 269M 3.41B 256M 251M 10.77B EV / Sales 2024
-
EV / Sales 2025 -
Free-Float
54.96%
Yield 2024 *
-
Yield 2025 -
1 day-0.56%
1 week-0.56%
Current month-0.56%
1 month-2.22%
3 months-33.58%
6 months-58.59%
Current year-29.88%
1 week 16.5
Extreme 16.5
18
1 month 15.3
Extreme 15.3
18.4
Current year 15.3
Extreme 15.3
60.9
1 year 15.3
Extreme 15.3
60.9
3 years 9
Extreme 9
60.9
5 years 9
Extreme 9
144
10 years 9
Extreme 9
175
Manager TitleAgeSince
Chief Executive Officer 57 2012-04-28
Director of Finance/CFO 51 2014-05-31
Chief Tech/Sci/R&D Officer - -
Director TitleAgeSince
Director/Board Member 57 2012-04-28
Chairman 69 2012-04-28
Director/Board Member 67 2012-04-28
Date Insider Type Main position Quantity % Market Cap. Importance
3/8/25 Expiration

Director

750,000 0.0642%
Change 5-day change 1-year change 3-year change Capi.($)
-0.56%-0.56%-18.14%+20.55% 65.46M
-2.37%-5.03%+39.49%+62.39% 62.23B
-0.73%-0.36%+9.89%+67.53% 54.92B
-0.14%+2.11%+16.96%+102.56% 55.26B
-3.33%-5.54%+19.39%+35.69% 42.59B
-2.45%-2.59%+16.36%+98.45% 41.08B
-1.64%+2.32%+219.80%+789.69% 40.33B
-0.87%+24.76%+101.20%+87.34% 33.12B
+0.21%+1.05%+14.81%+46.96% 32.61B
-2.90%+17.12%-42.35%+337.07% 23.98B
Average -1.46%+3.79%+37.74%+164.82% 38.62B
Weighted average by Cap. -1.51%+2.74%+44.33%+163.60%

Financials

2024 2025
Net sales - -
Net income -27.83M -0 -8.86M -7.91M -7.26M -6.6M -12.38M -839M -12.63M -86.7M -34.95M -443M -33.25M -32.54M -1.4B -24.49M -0 -7.8M -6.96M -6.39M -5.81M -10.9M -738M -11.11M -76.3M -30.76M -390M -29.27M -28.64M -1.23B
Net Debt 3.33M 0 1.06M 947K 869K 791K 1.48M 100M 1.51M 10.38M 4.19M 53.03M 3.98M 3.9M 167M 8.67M 0 2.76M 2.46M 2.26M 2.06M 3.86M 261M 3.93M 27.01M 10.89M 138M 10.36M 10.14M 436M
Projected Income Statement - Annual - Bonus BioGroup Ltd.
Logo Bonus BioGroup Ltd.
Bonus Biogroup Ltd, formerly Oceana Advanced Industries Ltd, is an Israel-based product-focused biotechnology company applying technology for supplying bone regeneration tissues. The Company is developing cell therapy products based on autologous and allogeneic bone implants that will enable efficient bone transplant and provide cellular-based bone replacement prosthetics for repairing bone lesions. It is targeting a worldwide market for the treatment of major disorders such as bone and cartilage related arthritis, osteoporosis, and various types of bones and joint trauma such as hip fractures and knee injuries, among others. On April 29, 2012, Bonus Bio Group Ltd fully acquired Bonus Therapeutic Ltd.
Employees
42
Date Price Change Volume
26-11-02 ILA 17.60 -0.56% 53,081
26-10-30 ILA 17.70 +0.57% 237,695
26-10-29 ILA 17.60 +0.57% 925,530
26-10-28 ILA 17.50 -1.13% 998,916
  1. Stock Market
  2. Stocks
  3. BONS Stock